Human CD19-specific switchable CAR T-cells are efficacious as constitutively active CAR T-cells but cause less morbidity in a mouse model of human CD19+ malignancy

Journal for immunotherapy of cancer

Heather Campbell, Meghan D Storlie, Sara Bolivar-Wagers, …, Sophie Viaud, Travis S Young, Bruce R Blazar

• DOI: 10.1136/jitc-2022-005934
• PMID: 36521930
• PMCID: PMC9756162